Steve Gavel

Steve Gavel currently serves as the Chief Commercial Officer at Cabaletta Bio, following a brief tenure in the same role at Orca Bio and as the Managing Partner at Celiance Consulting, which focuses on commercialization strategies for cell and gene therapies. Gavel has extensive experience in the biotechnology and pharmaceutical sectors, holding senior positions at Legend Biotech as Senior Vice President of Global Cell Therapy Commercial Development, and at Celgene as CAR-T US Commercial Development Lead and Executive Director of US Commercial Strategy. Gavel's background also includes leadership roles at Millennium Pharmaceuticals and IMS Health, where responsibilities encompassed marketing, strategic development, and business growth within oncology. Gavel holds a BS in Finance and Business Administration from Millersville University of Pennsylvania.